Equillium Stock Z Score

EQ Stock  USD 1.55  0.01  0.64%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Equillium Piotroski F Score and Equillium Valuation analysis.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
  
At this time, Equillium's Net Invested Capital is relatively stable compared to the past year. As of 05/21/2024, Capital Lease Obligations is likely to grow to about 905 K, while Capital Stock is likely to drop 2,161. At this time, Equillium's Interest Income is relatively stable compared to the past year. As of 05/21/2024, Interest Expense is likely to grow to about 748.9 K, while Net Loss is likely to drop (8.6 M).

Equillium Company Z Score Analysis

Equillium's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Equillium Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as Z Score. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.
0.920.96-0.87-0.730.55-0.380.650.90.550.76-0.911.00.9-0.850.810.520.690.80.29
0.920.96-0.71-0.440.27-0.340.560.750.240.8-0.950.920.99-0.810.590.190.430.640.02
0.960.96-0.75-0.60.31-0.370.690.820.310.79-0.970.960.92-0.920.690.390.550.710.29
-0.87-0.71-0.750.79-0.730.59-0.55-0.87-0.72-0.460.64-0.86-0.70.62-0.82-0.63-0.76-0.67-0.26
-0.73-0.44-0.60.79-0.720.37-0.66-0.89-0.85-0.330.49-0.73-0.390.69-0.95-0.94-0.96-0.85-0.67
0.550.270.31-0.73-0.72-0.480.320.630.930.36-0.20.540.29-0.230.720.720.730.560.2
-0.38-0.34-0.370.590.37-0.48-0.54-0.42-0.3-0.420.25-0.38-0.270.33-0.44-0.45-0.4-0.14-0.17
0.650.560.69-0.55-0.660.32-0.540.690.340.53-0.70.650.47-0.860.660.630.570.660.57
0.90.750.82-0.87-0.890.63-0.420.690.740.55-0.730.890.72-0.810.970.710.910.930.36
0.550.240.31-0.72-0.850.93-0.30.340.740.21-0.20.550.26-0.30.830.80.870.730.31
0.760.80.79-0.46-0.330.36-0.420.530.550.21-0.790.770.79-0.690.480.230.340.510.08
-0.91-0.95-0.970.640.49-0.20.25-0.7-0.73-0.2-0.79-0.91-0.920.91-0.58-0.27-0.42-0.68-0.23
1.00.920.96-0.86-0.730.54-0.380.650.890.550.77-0.910.9-0.850.80.520.680.80.29
0.90.990.92-0.7-0.390.29-0.270.470.720.260.79-0.920.9-0.730.560.120.40.63-0.09
-0.85-0.81-0.920.620.69-0.230.33-0.86-0.81-0.3-0.690.91-0.85-0.73-0.73-0.55-0.61-0.78-0.54
0.810.590.69-0.82-0.950.72-0.440.660.970.830.48-0.580.80.56-0.730.830.980.920.46
0.520.190.39-0.63-0.940.72-0.450.630.710.80.23-0.270.520.12-0.550.830.880.670.79
0.690.430.55-0.76-0.960.73-0.40.570.910.870.34-0.420.680.4-0.610.980.880.870.51
0.80.640.71-0.67-0.850.56-0.140.660.930.730.51-0.680.80.63-0.780.920.670.870.38
0.290.020.29-0.26-0.670.2-0.170.570.360.310.08-0.230.29-0.09-0.540.460.790.510.38
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

According to the company's disclosures, Equillium has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Equillium Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Equillium's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Equillium could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics of similar companies.
Equillium is currently under evaluation in z score category among related companies.

Equillium Current Valuation Drivers

We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap58.7M108.9M108.6M35.8M25.1M23.9M
Enterprise Value55.2M93.2M68.2M(13.2M)2.7M2.6M

Equillium Institutional Holders

Institutional Holdings refers to the ownership stake in Equillium that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Equillium's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Equillium's value.
Shares
Integrated Wealth Concepts Llc2023-12-31
40 K
Northern Trust Corp2023-12-31
35.2 K
Prudential Financial Inc2024-03-31
31.2 K
Capital Cs Group, Llc2023-12-31
19 K
Jane Street Group, Llc2023-12-31
12 K
Tower Research Capital Llc2023-12-31
9.4 K
Adar1 Capital Management Llc2023-12-31
6.5 K
Simplex Trading, Llc2024-03-31
5.2 K
Blackrock Inc2023-12-31
3.8 K
Decheng Capital Llc2023-12-31
4.4 M
Vanguard Group Inc2024-03-31
841.9 K

Equillium Fundamentals

About Equillium Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Equillium Piotroski F Score and Equillium Valuation analysis.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.35)
Revenue Per Share
1.085
Quarterly Revenue Growth
0.204
Return On Assets
(0.14)
Return On Equity
(0.48)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.